Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Although parallel assessment of PML-RAR alpha and RAR alpha-PML can enhance minimal residual disease detection in APL, this study demonstrates that treatment strategies involving determination of PCR status post-consolidation, even using RAR alpha-PML in addition to the more conventional PML-RAR alpha assay will fail to identify all patients at risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_assertion description "[Although parallel assessment of PML-RAR alpha and RAR alpha-PML can enhance minimal residual disease detection in APL, this study demonstrates that treatment strategies involving determination of PCR status post-consolidation, even using RAR alpha-PML in addition to the more conventional PML-RAR alpha assay will fail to identify all patients at risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638300.RAQlmnSuBbbk67-_9C63qdmdlQRkb73p1gAyU5aWjuGj8130_provenance.
• assertion description "[Although parallel assessment of PML-RAR alpha and RAR alpha-PML can enhance minimal residual disease detection in APL, this study demonstrates that treatment strategies involving determination of PCR status post-consolidation, even using RAR alpha-PML in addition to the more conventional PML-RAR alpha assay will fail to identify all patients at risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Although parallel assessment of PML-RAR alpha and RAR alpha-PML can enhance minimal residual disease detection in APL, this study demonstrates that treatment strategies involving determination of PCR status post-consolidation, even using RAR alpha-PML in addition to the more conventional PML-RAR alpha assay will fail to identify all patients at risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Although parallel assessment of PML-RAR alpha and RAR alpha-PML can enhance minimal residual disease detection in APL, this study demonstrates that treatment strategies involving determination of PCR status post-consolidation, even using RAR alpha-PML in addition to the more conventional PML-RAR alpha assay will fail to identify all patients at risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP1345587.RACmo8Pf7Q0ouv1usheFofOTjeyleD3Z03NTxsMRpja6Y130_assertion description "[Although parallel assessment of PML-RAR alpha and RAR alpha-PML can enhance minimal residual disease detection in APL, this study demonstrates that treatment strategies involving determination of PCR status post-consolidation, even using RAR alpha-PML in addition to the more conventional PML-RAR alpha assay will fail to identify all patients at risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1345587.RACmo8Pf7Q0ouv1usheFofOTjeyleD3Z03NTxsMRpja6Y130_provenance.
• NP632098.RAk15-6Z_Oe4RG4p72bjSKqq9s4WUz2dfgmGW1LTgVItI130_assertion description "[Although parallel assessment of PML-RAR alpha and RAR alpha-PML can enhance minimal residual disease detection in APL, this study demonstrates that treatment strategies involving determination of PCR status post-consolidation, even using RAR alpha-PML in addition to the more conventional PML-RAR alpha assay will fail to identify all patients at risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP632098.RAk15-6Z_Oe4RG4p72bjSKqq9s4WUz2dfgmGW1LTgVItI130_provenance.
• NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_assertion description "[Although parallel assessment of PML-RAR alpha and RAR alpha-PML can enhance minimal residual disease detection in APL, this study demonstrates that treatment strategies involving determination of PCR status post-consolidation, even using RAR alpha-PML in addition to the more conventional PML-RAR alpha assay will fail to identify all patients at risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1345585.RATDqGYGPvcI1z0rpqJGGQZw5atoayoPhnEOuNJuqOWkI130_provenance.
• NP1345588.RAa6ntNm7oPApz2zlvr8BV85XU0RyALJixUUMNfdyzFiI130_assertion description "[Although parallel assessment of PML-RAR alpha and RAR alpha-PML can enhance minimal residual disease detection in APL, this study demonstrates that treatment strategies involving determination of PCR status post-consolidation, even using RAR alpha-PML in addition to the more conventional PML-RAR alpha assay will fail to identify all patients at risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1345588.RAa6ntNm7oPApz2zlvr8BV85XU0RyALJixUUMNfdyzFiI130_provenance.
• NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_assertion description "[Although parallel assessment of PML-RAR alpha and RAR alpha-PML can enhance minimal residual disease detection in APL, this study demonstrates that treatment strategies involving determination of PCR status post-consolidation, even using RAR alpha-PML in addition to the more conventional PML-RAR alpha assay will fail to identify all patients at risk of relapse.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP954843.RA0AtsrZSMe3xBFH2yUDvx63pqUnWBnzt4nveNKGSRclI130_provenance.